NIH-funded research NIH-funded research

Exploring how heme enzymes work and their role in diseases

Official title: Mechanistic Investigation into Nitric Oxide Interconversion Pathways of Heme Enzymes using Synthetic Mimics

Funded at University of Alabama in Tuscaloosa · NIH-11112518 · Data updated 2026-11-12

This study is looking at how certain important enzymes in our body work, using special compounds to mimic them, and the goal is to find new treatment options for conditions like autoimmune diseases and cancer that could help patients feel better.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Alabama in Tuscaloosa
NIH-funded
Lab location1 site (Tuscaloosa, United States)
Project startJune 15, 2024
Project endApril 30, 2029
Funding year2025
Award (this year)$363,934
NIH project number5R35GM154981-02
Project IDNIH-11112518 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals suffering from autoimmune diseases or cancers where heme enzymes are implicated.

Less likely to help

Patients with conditions unrelated to heme enzyme activity may not receive any benefit from this research.

What this research studies

This research investigates the mechanisms of heme enzymes, which are crucial for various biological reactions in the body. By using synthetic mimic compounds, the study aims to understand how these enzymes function, particularly focusing on mid-valent heme species that are often overlooked. The findings could lead to the development of targeted therapies for conditions like autoimmune diseases and cancer, where these enzymes play a significant role. Patients may benefit from new treatment options that arise from a better understanding of these enzymes.

Why it matters

Potential benefit: If successful, this research could lead to innovative therapies for autoimmune diseases and cancer by targeting heme enzymes more effectively.

How similar studies have gone: While the study of heme enzymes is well-established, the specific focus on mid-valent heme species is relatively novel and has not been extensively tested in prior research.

Where this research is happening

  • University of Alabama in Tuscaloosa
    Tuscaloosa, United States
    Active

Researchers

  • Principal investigator: Wijeratne, Gayan B — University of Alabama in Tuscaloosa
  • Study coordinator: Wijeratne, Gayan B

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.